Weifeng Luo

908 total citations
27 papers, 399 citations indexed

About

Weifeng Luo is a scholar working on Molecular Biology, Plant Science and Physiology. According to data from OpenAlex, Weifeng Luo has authored 27 papers receiving a total of 399 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 8 papers in Plant Science and 4 papers in Physiology. Recurrent topics in Weifeng Luo's work include CRISPR and Genetic Engineering (6 papers), Adenosine and Purinergic Signaling (4 papers) and Plant tissue culture and regeneration (4 papers). Weifeng Luo is often cited by papers focused on CRISPR and Genetic Engineering (6 papers), Adenosine and Purinergic Signaling (4 papers) and Plant tissue culture and regeneration (4 papers). Weifeng Luo collaborates with scholars based in United States, Japan and China. Weifeng Luo's co-authors include Steven K. Hanks, Joyce Cheung‐Flynn, Mei Xu, Colleen M. Brophy, Carla Grandori, David J. Elzi, Denise A. Galloway, Jan Brábek, Amy‐Joan L. Ham and Raghothama Chaerkady and has published in prestigious journals such as Nature Communications, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Weifeng Luo

25 papers receiving 393 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Weifeng Luo United States 11 233 98 42 41 34 27 399
Flávia G. Ghiraldini Brazil 10 194 0.8× 35 0.4× 25 0.6× 34 0.8× 31 0.9× 12 303
Marfoua S. Ali Libya 9 144 0.6× 46 0.5× 15 0.4× 22 0.5× 31 0.9× 19 369
Lian Wang China 10 376 1.6× 53 0.5× 17 0.4× 42 1.0× 34 1.0× 33 668
Weiwei Hao China 12 208 0.9× 135 1.4× 9 0.2× 24 0.6× 34 1.0× 36 416
Sara Alves Portugal 9 294 1.3× 27 0.3× 43 1.0× 41 1.0× 85 2.5× 16 422
Zhi Ling China 5 232 1.0× 20 0.2× 69 1.6× 56 1.4× 84 2.5× 8 405
Leena Bashyam India 10 207 0.9× 53 0.5× 22 0.5× 34 0.8× 34 1.0× 13 362
Gerd Heimlich Germany 8 326 1.4× 23 0.2× 32 0.8× 45 1.1× 87 2.6× 8 448
Anna Łukasik Poland 10 394 1.7× 93 0.9× 20 0.5× 15 0.4× 34 1.0× 14 537
Juliette Martin Switzerland 9 208 0.9× 19 0.2× 32 0.8× 45 1.1× 41 1.2× 13 328

Countries citing papers authored by Weifeng Luo

Since Specialization
Citations

This map shows the geographic impact of Weifeng Luo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Weifeng Luo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Weifeng Luo more than expected).

Fields of papers citing papers by Weifeng Luo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Weifeng Luo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Weifeng Luo. The network helps show where Weifeng Luo may publish in the future.

Co-authorship network of co-authors of Weifeng Luo

This figure shows the co-authorship network connecting the top 25 collaborators of Weifeng Luo. A scholar is included among the top collaborators of Weifeng Luo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Weifeng Luo. Weifeng Luo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Luo, Weifeng, Qing Ji, Alan L. Eggenberger, et al.. (2025). Enhancing biolistic plant transformation and genome editing with a flow guiding barrel. Nature Communications. 16(1). 5624–5624. 4 indexed citations
2.
Luo, Weifeng, Selda Örs, Hong Fang, et al.. (2025). Efficient genome editing by CRISPR-Cas12a in common wheat via shoot apical meristem delivery. PLANT PHYSIOLOGY. 199(4).
3.
Yang, Jinming, Weifeng Luo, Patricia A. Ward, et al.. (2025). Combined treatment with CDK4/6, CDK2, and CXCR1/2 inhibitors effectively halts the growth of BRAF wild-type melanoma tumors. Frontiers in Oncology. 15. 1609735–1609735.
4.
Luo, Weifeng, Yuelin Liu, & Ryozo Imai. (2024). In Planta Genome Editing in Commercial Wheat Varieties: Use of TaQsd1 to Lengthen Seed Dormancy. Methods in molecular biology. 2830. 163–171. 2 indexed citations
5.
Liu, Yuelin, Weifeng Luo, Qianyan Linghu, et al.. (2021). In planta Genome Editing in Commercial Wheat Varieties. Frontiers in Plant Science. 12. 648841–648841. 31 indexed citations
6.
Luo, Weifeng, Setsuko Komatsu, Tatsuya Abé, Hideyuki Matsuura, & Kosaku Takahashi. (2020). Comparative Proteomic Analysis of Wild-Type Physcomitrella Patens and an OPDA-Deficient Physcomitrella Patens Mutant with Disrupted PpAOS1 and PpAOS2 Genes after Wounding. International Journal of Molecular Sciences. 21(4). 1417–1417. 9 indexed citations
7.
Zhang, Yuping, Xiaolei Wei, Zhi Yu, et al.. (2020). CD8+GITR+ T cells may negatively regulate T cell overactivation in aplastic anemia. Immunological Investigations. 50(4). 406–415. 6 indexed citations
8.
Zhao, Suwen, Yuping Zhang, Weifeng Luo, et al.. (2019). Increased CD8+CD27+perforin+ T cells and decreased CD8+CD70+ T cells may be immune biomarkers for aplastic anemia severity. Blood Cells Molecules and Diseases. 77. 34–42. 7 indexed citations
9.
Luo, Weifeng, et al.. (2019). Medial artery calcification increases neointimal hyperplasia after balloon injury. Scientific Reports. 9(1). 8193–8193. 10 indexed citations
10.
Cheung‐Flynn, Joyce, Bret D. Alvis, Kyle M. Hocking, et al.. (2019). Normal Saline solutions cause endothelial dysfunction through loss of membrane integrity, ATP release, and inflammatory responses mediated by P2X7R/p38 MAPK/MK2 signaling pathways. PLoS ONE. 14(8). e0220893–e0220893. 19 indexed citations
12.
Komalavilas, Padmini, et al.. (2017). Vascular surgical stretch injury leads to activation of P2X7 receptors and impaired endothelial function. PLoS ONE. 12(11). e0188069–e0188069. 10 indexed citations
13.
Luo, Weifeng, et al.. (2017). P2X7R antagonism after subfailure overstretch injury of blood vessels reverses vasomotor dysfunction and prevents apoptosis. Purinergic Signalling. 13(4). 579–590. 15 indexed citations
14.
Luo, Weifeng, et al.. (2016). Subfailure Overstretch Injury Leads to Reversible Functional Impairment and Purinergic P2X7 Receptor Activation in Intact Vascular Tissue. Frontiers in Bioengineering and Biotechnology. 4. 75–75. 7 indexed citations
15.
Hocking, Kyle M., et al.. (2015). Brilliant blue FCF is a nontoxic dye for saphenous vein graft marking that abrogates response to injury. Journal of Vascular Surgery. 64(1). 210–218. 16 indexed citations
16.
McKinley, Eliot T., Huiling Liu, W. Hayes McDonald, et al.. (2013). Global Phosphotyrosine Proteomics Identifies PKCδ as a Marker of Responsiveness to Src Inhibition in Colorectal Cancer. PLoS ONE. 8(11). e80207–e80207. 14 indexed citations
17.
Xu, Mei, Weifeng Luo, David J. Elzi, Carla Grandori, & Denise A. Galloway. (2008). NFX1 Interacts with mSin3A/Histone Deacetylase To Repress hTERT Transcription in Keratinocytes. Molecular and Cellular Biology. 28(15). 4819–4828. 55 indexed citations
18.
Luo, Weifeng, Robbert J.C. Slebos, Salisha Hill, et al.. (2008). Global Impact of Oncogenic Src on a Phosphotyrosine Proteome. Journal of Proteome Research. 7(8). 3447–3460. 88 indexed citations
19.
Liang, Yu, Huijun Zhi, Weifeng Luo, et al.. (2002). [Construction and identification of the replication-deficient recombinant vaccinia virus co-expressing HPV type 16 L1 and L2 proteins].. PubMed. 16(3). 256–60. 1 indexed citations
20.
Zhi, Huijun, et al.. (2002). [Construction of recombinant vaccinia virus co-expressing mutant E6 plus E7 proteins and detection of its immunogenicity and antitumor response].. PubMed. 16(4). 341–4. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026